Process of modulating man5 and/or afucosylation content of a glycoprotein composition

US10059770B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10059770-B2
Application numberUS-201314374163-A
CountryUS
Kind codeB2
Filing dateJan 18, 2013
Priority dateJan 30, 2012
Publication dateAug 28, 2018
Grant dateAug 28, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a method for producing glycoprotein composition with an increased percentage of Man5 and/or afucosylated glycans. Use of manganese for increasing the percentage of Man5 and afucosylated glycans in glycoprotein composition is further provided.

First claim

Opening claim text (preview).

We claim: 1. A cell culture process for obtaining an antibody composition comprising increased percentage of Man5 glycans and afucosylated glycans by culturing Chinese hamster ovary (CHO) cells expressing said antibody composition in culture medium comprising a) divalent manganese ion or its salts thereof at a concentration of 2 μM to 20 μM b) at a pH of about 6.8 to about 7.2 c) recovering the antibody composition from the cell culture. 2. The process according to claim 1 , wherein the antibody composition comprises about 4.5% to about 11% afucosylated glycans. 3. The process according to claim 1 , wherein the antibody composition comprises about 8% to about 22% Man5 glycans. 4. The process according to claim 1 , wherein the antibody composition comprises about 4.5% to about 11% afucosylated glycans and about 8% to about 22% Man5 glycans. 5. The process according to claim 1 , wherein the said process further comprises addition of a feed. 6. The process according to claim 1 , wherein the said process further comprises subjecting cells to a temperature shift wherein cells are cultured a) at first temperature for a first period of time and b) at second temperature for a second period of time. 7. A cell culture process for obtaining an antibody composition comprising increased percentage of Man5 glycans and afucosylated glycans by culturing CHO cells expressing said antibody composition in culture medium comprising the steps of: a) culturing the cells at a first temperature for a first period of time and a pH of about 6.8 to 7.2; b) supplementing the cells with divalent manganese ions or its salts thereof at a concentration of 2 μM to 20 μM; c) subjecting the cells to a temperature shift wherein the cells are cultured at a second temperature for a second period of time; and d) recovering the antibody composition from the cell culture. 8. The process according to claim 7 , wherein the cells are first cultured at a first temperature of about 37° C. 9. The process according to claim 7 , wherein the cells are shifted to a second temperature of about 31° C. to about 35° C. 10. The process according to claim 7 , wherein the cells are shifted to a second temperature of about 35° C. 11. The process according to claim 7 , wherein the cells are shifted to a second temperature of about 33° C. 12. The process according to claim 7 , wherein the cells are shifted to a second temperature of about 31° C. 13. A cell culture process for obtaining an antibody composition comprising about 8% to about 22% of Man5 glycans and about 4.5% to about 11% of afucosylated glycans by culturing CHO cells expressing said antibody composition in culture medium comprising the steps of: a) culturing the cells at a first temperature of about 37° C. for a period of time and a pH of about 6.8 to 7.2: b) supplementing the cells with divalent manganese ions or its salts thereof at a concentration of 2 μM to 20 μM; c) subjecting the cells to a temperature shift and culturing the cells at a second temperature for a second period of time; and d) recovering the antibody composition from the cell culture.

Assignees

Inventors

Classifications

  • Glycosylation, sialylation, or fucosylation · CPC title

  • Transition metals · CPC title

  • Glycopeptides, glycoproteins · CPC title

  • Sugars · CPC title

  • Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound (C12N1/34 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10059770B2 cover?
Provided is a method for producing glycoprotein composition with an increased percentage of Man5 and/or afucosylated glycans. Use of manganese for increasing the percentage of Man5 and afucosylated glycans in glycoprotein composition is further provided.
Who is the assignee on this patent?
Dr Reddys Laboratories Ltd
What technology area does this patent fall under?
Primary CPC classification C07K16/2863. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).